Spots Global Cancer Trial Database for recurrent gbm
Every month we try and update this database with for recurrent gbm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | NCT02858895 | Glioblastoma Grade IV Astroc... Glioblastoma Mu... Grade IV Glioma | MDNA55 | 18 Years - | Medicenna Therapeutics, Inc. | |
| Ph. 2 Sorafenib + Protracted Temozolomide in Recurrent GBM | NCT00597493 | Recurrent Gliob... | Sorafenib and T... | 18 Years - | Duke University | |
| Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM | NCT00612989 | Glioblastoma Gliosarcoma | Temodar and O6-... | 18 Years - | Duke University | |
| Tryptophan Metabolism in Human Brain Tumors | NCT02367482 | Glioblastoma | 22 Years - | Wayne State University | ||
| Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT | NCT04763031 | Glioblastoma GBM Recurrent GBM | Intra-operative... | 18 Years - | Parkridge Medical Center | |
| Ph II Bevacizumab + Etoposide for Pts w Recurrent MG | NCT00612430 | Glioblastoma Gliosarcoma | Bevacizumab and... | 18 Years - | Duke University | |
| The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | NCT00076986 | Glioblastoma Mu... | IL13-PE38QQR surgery and cat... prolifespan 20 ... surgery and waf... | 18 Years - | INSYS Therapeutics Inc | |
| VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM | NCT03149575 | Glioblastoma Mu... Glioblastoma Glioma GBM Brain Cancer | VAL-083, Dianhy... Physician's Cho... Physician's Cho... Physician's Cho... | 18 Years - | Kintara Therapeutics, Inc. | |
| A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE) | NCT02511405 | Glioblastoma | VB-111 + bevaci... Bevacizumab | 18 Years - | Vascular Biogenics Ltd. operating as VBL Therapeutics | |
| Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma | NCT02704858 | Glioblastoma Mu... | Perillyl alcoho... | 18 Years - | Neonc Technologies, Inc. | |
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | NCT02858895 | Glioblastoma Grade IV Astroc... Glioblastoma Mu... Grade IV Glioma | MDNA55 | 18 Years - | Medicenna Therapeutics, Inc. | |
| Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab | NCT04681677 | Glioblastoma Recurrent Gliob... GBM Recurrent GBM | Radiation: Intr... Bevacizumab | 18 Years - | Xoft, Inc. | |
| The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme | NCT00076986 | Glioblastoma Mu... | IL13-PE38QQR surgery and cat... prolifespan 20 ... surgery and waf... | 18 Years - | INSYS Therapeutics Inc | |
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM | NCT04489420 | Astrocytoma, Gr... Giant Cell Glio... Glioblastoma Mu... Cyclophosphamid... Immunosuppressi... Immunologic Fac... Physiological E... Molecular Mecha... Antiviral Agent... Anti-infective ... Analgesics, Non... Analgesics Sensory System ... Peripheral Nerv... | CYNK001-IV CYNK001-IT | 18 Years - | Celularity Incorporated | |
| A Phase 0 /II Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection | NCT03834740 | Glioblastoma Mu... Glioma of Brain | Ribociclib Everolimus | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| A Phase 0 /II Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection | NCT03834740 | Glioblastoma Mu... Glioma of Brain | Ribociclib Everolimus | 18 Years - | St. Joseph's Hospital and Medical Center, Phoenix | |
| Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma | NCT02704858 | Glioblastoma Mu... | Perillyl alcoho... | 18 Years - | Neonc Technologies, Inc. | |
| Ph I 5-day Temozolomide + O6-BG in Treatment of Pts w Recurrent / Progressive GBM | NCT00612989 | Glioblastoma Gliosarcoma | Temodar and O6-... | 18 Years - | Duke University | |
| Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma | NCT01478178 | Glioma Glioblastoma Glioblastoma Mu... GBM Brain Cancer | VAL-083 (Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma | NCT03782415 | Glioblastoma Recurrent Gliob... GBM Newly Diagnosed... | MN-166 Temozolomide | 18 Years - | MediciNova | |
| Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting | NCT02717962 | Glioma Glioblastoma Glioblastoma Mu... GBM Brain Cancer | VAL-083, Dianhy... | 18 Years - | Kintara Therapeutics, Inc. | |
| TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine | NCT04671459 | Glioblastoma Mu... Recurrent Gliob... | TTFields and SR... | 18 Years - | Prof. Franciszek Lukaszczyk Memorial Oncology Center | |
| Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma | NCT00611325 | Glioblastoma Gliosarcoma | Avastin Bortezomib | 18 Years - | Duke University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
